Current acceptance of the HPV vaccine.
Miller
Megan M
MM
Growing Child Pediatrics, Raleigh, NC, USA.
Wilson
Julie M
JM
Waldrop
Julee
J
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006287:Health Planning Guidelines; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D009722:Nurse Practitioners; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000276:immunology*; D010290:Parents / Q000193:education / Q000523:psychology; D010342:Patient Acceptance of Health Care; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D012449:Safety; D012749:Sexually Transmitted Diseases / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology*
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines